Weiwei Cao

425 total citations
26 papers, 307 citations indexed

About

Weiwei Cao is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Weiwei Cao has authored 26 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Weiwei Cao's work include Pulmonary Hypertension Research and Treatments (6 papers), MicroRNA in disease regulation (3 papers) and Ginseng Biological Effects and Applications (2 papers). Weiwei Cao is often cited by papers focused on Pulmonary Hypertension Research and Treatments (6 papers), MicroRNA in disease regulation (3 papers) and Ginseng Biological Effects and Applications (2 papers). Weiwei Cao collaborates with scholars based in China, Hong Kong and United States. Weiwei Cao's co-authors include Daling Zhu, Xiaodong Zheng, Hao Xing, Lei Yu, Hongyang Chen, Yan Xing, Tingting Shen, Shuang Wang, Hongxia Bao and Xiaowei Nie and has published in prestigious journals such as Coordination Chemistry Reviews, The International Journal of Biochemistry & Cell Biology and Frontiers in Pharmacology.

In The Last Decade

Weiwei Cao

22 papers receiving 304 citations

Peers

Weiwei Cao

PRM

PHARM

PHYSI

Zhijia Li China

Huang Huang China

Ziv Radisavljevic United States

Eman Khairy Egypt

Guorong Wen China

Haifeng Yang China

Besnik Muqaku Austria

İlhan Yaylım Türkiye

Vijaya Paul Samuel India

Zhijia Li China

Weiwei Cao

279 ×1.8

73 ×0.8

PRM

79 ×1.0

29 ×0.9

PHARM

58 ×2.1

PHYSI

Citations per year, relative to Weiwei Cao Weiwei Cao (= 1×) peers Zhijia Li

Countries citing papers authored by Weiwei Cao

Since Specialization

Citations

This map shows the geographic impact of Weiwei Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Cao more than expected).

Fields of papers citing papers by Weiwei Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Cao. The network helps show where Weiwei Cao may publish in the future.

Co-authorship network of co-authors of Weiwei Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Cao. A scholar is included among the top collaborators of Weiwei Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Cao. Weiwei Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Jingya, Xu Wang, Xinru Wang, et al.. (2025). Super‐Enhancer Target Gene CBP/p300‐Interacting Transactivator With Glu/Asp‐Rich C‐Terminal Domain, 2 Cooperates With Transcription Factor Forkhead Box J3 to Inhibit Pulmonary Vascular Remodeling. Cell Proliferation. 58(11). e13817–e13817.

Li, Xuan, Tianhui Wu, Meiqi Liu, et al.. (2025). Ce-centered polyhedral arrangement pattern and optical performance in Ce-based nonlinear optical materials. Chinese Chemical Letters. 112090–112090.

Wu, Tianhui, Jiahang Liu, Meiqi Liu, et al.. (2025). Recent achievements of d0 transition-metal-based oxyfluorides: Crystal chemistry and application in second-order NLO materials. Coordination Chemistry Reviews. 549. 217347–217347.

Su, Rui, Weiwei Cao, Guoxu Ma, et al.. (2024). Cyclohexene oxide CA, a derivative of zeylenone, exhibits anti-cancer activity in glioblastoma by inducing G0/G1 phase arrest through interference with EZH2. Frontiers in Pharmacology. 14. 1326245–1326245. 3 indexed citations

Cao, Weiwei, et al.. (2023). Qiangxin recipe improves doxorubicin-induced chronic heart failure by enhancing KLF5-mediated glucose metabolism. Phytomedicine. 112. 154697–154697. 9 indexed citations

Cao, Weiwei, et al.. (2022). Application of artificial intelligence in the diagnosis and prognostic prediction of ovarian cancer. Computers in Biology and Medicine. 146. 105608–105608. 23 indexed citations

Meng, Xiangbao, Yuan Zhang, Zongyang Li, et al.. (2022). A novel natural PPARγ agonist, Gypenoside LXXV, ameliorates cognitive deficits by enhancing brain glucose uptake via the activation of Akt/GLUT4 signaling in db/db mice. Phytotherapy Research. 36(4). 1770–1784. 12 indexed citations

Zhang, Jun, et al.. (2022). Aberrant expression of GSTM5 in lung adenocarcinoma is associated with DNA hypermethylation and poor prognosis. BMC Cancer. 22(1). 685–685. 12 indexed citations

Li, Song, et al.. (2020). Protective Effects of Puerarin on Premature Ovarian Failure via Regulation of Wnt/β-catenin Signaling Pathway and Oxidative Stress. Reproductive Sciences. 28(4). 982–990. 26 indexed citations

10.

Wang, Shuang, Weiwei Cao, Shan Gao, et al.. (2019). TUG1 Regulates Pulmonary Arterial Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension. Canadian Journal of Cardiology. 35(11). 1534–1545. 33 indexed citations

11.

He, Fa, Jianfeng Yang, Rui Wang, et al.. (2019). 8-methoxysmyrindiol from Gerbera piloselloides (L.) Cass. and its vasodilation effects on isolated rat mesenteric arteries. Fitoterapia. 138. 104299–104299. 10 indexed citations

12.

Xing, Yan, Xiaodong Zheng, Jing Qi, et al.. (2018). 15-Lipoxygenase/15-hydroxyeicosanoid and activator protein 1 contribute to hypoxia-induced pulmonary artery smooth muscle cells phenotype alteration. Prostaglandins Leukotrienes and Essential Fatty Acids. 135. 22–29. 7 indexed citations

13.

Yu, Lei, Yingfeng Tu, Li Liu, et al.. (2017). Resveratrol Protects Against Pulmonary Arterial Hypertension in Rats via Activation of Silent Information Regulator 1. Cellular Physiology and Biochemistry. 42(1). 55–67. 41 indexed citations

14.

Wang, Mengmeng, He Li, Fang-Fang Zhang, et al.. (2017). [Role of calcium-sensing receptor in neonatal mice with persistent pulmonary hypertension].. PubMed. 19(2). 208–214. 3 indexed citations

15.

Song, Shasha, Min Zhang, Min Mao, et al.. (2016). Hypoxia inhibits pulmonary artery endothelial cell apoptosis via the e-selectin/biliverdin reductase pathway. Microvascular Research. 106. 44–56. 8 indexed citations

16.

Cao, Weiwei, et al.. (2015). Protective effect of 2-deoxy-D-glucose on the cytotoxicity of cyclosporin A in vitro. Molecular Medicine Reports. 12(2). 2814–2820. 1 indexed citations

17.

Xing, Yan, Xiaodong Zheng, Guixia Li, et al.. (2015). MicroRNA-30c contributes to the development of hypoxia pulmonary hypertension by inhibiting platelet-derived growth factor receptor β expression. The International Journal of Biochemistry & Cell Biology. 64. 155–166. 26 indexed citations

18.

Wang, Shuang, Weiwei Cao, Qian Li, et al.. (2015). Activation of ERK pathway is required for 15-HETE-induced angiogenesis in human umbilical vascular endothelial cells. Journal of Receptors and Signal Transduction. 36(3). 225–232. 12 indexed citations

19.

Zhang, Bo, et al.. (2014). Inhibition of CXCL12/CXCR4 suppresses pulmonary arterial smooth muscle cell proliferation and cell cycle progression via PI3K/Akt pathway under hypoxia. Journal of Receptors and Signal Transduction. 35(4). 329–339. 25 indexed citations

20.

Cao, Weiwei, et al.. (2014). Protective effects of 2-deoxy-D-glucose on nephrotoxicity induced by cyclosporine A in rats.. PubMed. 7(8). 4587–95. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact